Cited by 315Antifungal resistance and susceptibilityFungal and yeast genetics researchFungal Infections and Studies

Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections.

Steinbach, William J., Reedy, Jennifer L., Cramer, Robert A., Perfect, John R., Heitman, Joseph·2007·Nature Reviews Microbiology

Abstract

The number of immunocompromised patients with invasive fungal infections continues to increase and new antifungal therapies are not keeping pace with the growing incidence of these infections and their associated mortality. Calcineurin inhibition is currently used to exert effective immunosuppression following organ transplantation and in treating various other conditions. However, the calcineurin pathway is also intricately involved in the growth and pathogenesis of the three major fungal pathogens of humans, Cryptococcus neoformans, Candida albicans and Aspergillus fumigatus, and the exploitation of fungal calcineurin pathways holds great promise for the future development of novel antifungal agents. This Review summarizes our current understanding of calcineurin biology in these fungal species, and its exciting potential role in treating invasive fungal infections.

Integrity signals

Registry

Crossref · 10.1038/nrmicro1680

Cites

134 of 134 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Steinbach, W. J., Reedy, J. L., Cramer, R. A., Perfect, J. R., & Heitman, J.
Affiliations
  • Duke University (US)
  • Duke Medical Center (US)
Corresponding author
Steinbach, William J.
Venue
Nature Reviews Microbiology
Published
2007-06
Volume
5
Issue
6
Pages
418-430
ISSN
  • 1740-1526 (ISSN-L)
  • 1740-1534
OpenAlex
W2081581252
Cited by
313
References
132
Citations by year
2026: 3 · 2025: 4 · 2024: 9 · 2023: 9 · 2022: 13 · 2021: 10 · 2020: 23 · 2019: 15 · 2018: 13 · 2017: 23 · 2016: 23 · 2015: 20 · 2014: 26 · 2013: 17 · 2012: 20
FWCI
2.49
Type
journal article
Language
en
Open access
closed
Locations
  • Nature Reviews Microbiology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
  • Health Sciences › Medicine › Epidemiology › Fungal Infections and Studies
Keywords
calcineurin, calcineurin inhibition, antifungal agents, invasive fungal infections, Cryptococcus neoformans, Candida albicans, Aspergillus fumigatus, immunocompromised patients, fungal pathogenesis, calcineurin pathway
MeSH terms
Antifungal Agents, Fungi, Humans, Mycoses, Signal Transduction, Calcineurin, Calcineurin Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review